Developer docs
API playgroundTry for free, no card

Search company profiles

Scarab Genomics LLC.

Full company profile

uuid000l3mw

Namestring
Scarab Genomics LLC.
Legal namestring
Scarab Genomics LLC
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Scarab Genomics LLC, founded in 2002 in Madison, Wisconsin by Professor Frederick Blattner, commercializes engineered reduced-genome E. coli host strains under the Clean Genome® brand, derived from the MDS42 strain published in Science 312:1044-6. Its core platform removes approximately 20% of the E. coli genome, including all mobile genetic elements, insertion sequences, bacteriophages, and nonessential genes, delivering enhanced genetic stability and enabling long continuous fermentation runs. The C-Flow™ continuous fermentation system (US Patent 10,604,736) allows kilogram-scale biopharmaceutical production in 10-liter fermenters, and complementary IP (US Patent 11,174,284) covers improved CRM197 purification for conjugate vaccine manufacturing.

The company sells a catalog of Clean Genome® variants (base, ΔrecA, LowMut, LowMut ΔrecA Blue, LowMut T7, plus specialty strains for dsRNA, low endotoxin, methylation-deficient, protease-deleted, and toxin-antitoxin-deleted applications), vaccine carrier proteins (CRM197 and Protein D), the pSX2 expression vector, and an Insertion Sequence Detection Kit. Pricing on the self-serve e-commerce store ranges from $225 to $3,350 per unit. Scarab serves academic researchers under a limited license, biopharmaceutical manufacturers and CDMOs under negotiated commercial licenses, and has granted Bionova Scientific an exclusive license for plasmid DNA production (February 2026), with World Fusion distributing in Japan from December 2025. Revenue is generated through product sales, academic and commercial licensing royalties, and exclusive technology licensing arrangements.

Short descriptiontext

Scarab Genomics LLC develops and commercializes engineered reduced-genome Clean Genome® E. coli strains, vaccine carrier proteins, and C-Flow™ continuous fermentation technology for biopharmaceutical manufacturers, CDMOs, vaccine developers, and academic researchers producing recombinant proteins and nucleic acids.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMadison, United States
HQ citystring
Madison
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
engineered E. coli strains, vaccine carrier proteins, continuous fermentation, recombinant protein expression, plasmid DNA production
Industry5 codes
PRIMARYHLAGAGAC
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAKAE
Plasmid DNA & mRNA Manufacturing Services
SECONDARYHLAAAEAD
Vaccine Technology Platforms (mRNA, viral vector, protein subunit, inactivated/live-attenuated, VLP, DNA)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAAAAAB
Recombinant Protein Therapeutics (enzymes, hormones, growth factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAACAN
Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Bioprocessing and Synthetic Biology Reagents
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Product Sales
TypeOne Time License
Description

Direct sales of Clean Genome E. coli competent cells, vaccine carrier proteins (CRM197, Protein D), expression vectors, and detection kits through e-commerce platform. Products available in various sizes with pricing from $225 to $3,350.

scarabgenomics.com
2Academic Licensing
TypeLicensing Royalties
Description

Limited Use License Agreement for academic research use of Clean Genome strains; requires signed agreement prior to shipping.

scarabgenomics.com
3Commercial Licensing
TypeLicensing Royalties
Description

Commercial licenses negotiated for production use of Clean Genome E. coli and C-Flow fermentation technology; includes access to technical experts for strain and expression optimization.

scarabgenomics.com
4Exclusive Technology Licensing
TypeLicensing Royalties
Description

Partnership with Bionova Scientific granting exclusive rights for Clean Genome strains in specific applications (plasmid DNA production), with licensing fees and potential milestone payments.

scarabgenomics.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Pricing details8 tiers
1Clean Genome E. coli competent cells
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$890.00 - $3,350.00 depending on strain variant and pack size (5, 10, or 20 transformations). Available as chemically competent or electrocompetent cells.

scarabgenomics.com
2CRM197 protein vaccine carrier
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$225.00 - $2,000.00 depending on quantity (1mg, 10mg, 20mg). Research use only, not for human use.

scarabgenomics.com
3Protein D vaccine carrier
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$225.00 - $2,000.00 depending on quantity (1mg, 10mg, 20mg). Research use only.

scarabgenomics.com
4pSX2 Expression Vector
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$400.00 for 10μg vector in 10mM Tris-HCl, pH 8.0, 1mM EDTA. Store at ≤-70°C.

scarabgenomics.com
5Insertion Sequence Detection Kit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,000.00 including positive/negative control DNA and IS-specific primers for 10 samples. Dry ice shipping required.

scarabgenomics.com
6Shipping and Handling
ModelOtherBilling cadencePay-as-you-go
Notes

Domestic shipping: $160 flat rate + $25 dry ice fee. International: $50 dry ice + shipping charged to FedEx account. 14-day window to report lost/damaged shipments.

scarabgenomics.com
7Academic Research License
ModelSubscriptionBilling cadenceAnnual
Notes

Limited Use License Agreement required; no separate fee mentioned - included with product purchase for qualified academic institutions.

scarabgenomics.com
8Commercial Production License
ModelLicensing/ royaltiesBilling cadenceMulti-year contract
Notes

Negotiated licensing agreement required; pricing determined based on commercial use terms; contact sales team for quote.

scarabgenomics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Clean Genome
Description

Engineered E. coli strains with reduced genomes for enhanced genetic stability and improved metabolic efficiency in protein and nucleic acid production.

scarabgenomics.com
+2 more records
Core offering1 text field

Scarab Genomics LLC develops and commercializes Clean Genome® engineered reduced-genome E. coli strains for high-efficiency production of recombinant proteins and nucleic acids, including biopharmaceutical manufacturing. The company also sells vaccine carrier proteins (CRM197 and Protein D), the pSX2 expression vector, an Insertion Sequence Detection Kit, and licenses its C-Flow™ continuous fermentation technology for commercial-scale biopharmaceutical production.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Continuous fermentation runs up to 65 days with consistent production levels
+5 more records
Product overview1 text field

Scarab Genomics LLC offers a platform of Clean Genome® engineered E. coli strains for high-efficiency production of recombinant proteins and nucleic acids. The core product line includes Clean Genome® base strain and specialized variants (ΔrecA, LowMut, LowMut ΔrecA, LowMut ΔrecA Blue, LowMut T7), all derived from the MDS42 reduced-genome strain. Supporting products include vaccine carrier proteins CRM197 and Protein D for conjugate vaccine research, the pSX2 expression vector, and the Insertion Sequence Detection Kit for quality control. The C-Flow™ continuous fermentation system enables scalable biopharmaceutical production with small-footprint equipment. Products are available for research use via limited license and for commercial use through licensing agreements.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-05
Description

Partnership enables Bionova to leverage Clean Genome platform eliminating mobile genetic elements and minimizing genomic instability to achieve higher plasmid yields and improved lot-to-lot consistency for advanced biologics manufacturing.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-02-03
Description

Exclusive licensing partnership granting Bionova Scientific rights to use Scarab's proprietary Clean Genome engineered E. coli strains for plasmid DNA production. The partnership enables Bionova to support client programs across mRNA, viral vectors, and emerging genetic medicine platforms with scalable, regulatory-aligned manufacturing solutions. Bionova operates protein operations in Fremont, California and plasmid DNA facility in Houston, Texas.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-22
Description

World Fusion serves as the authorized distributor of Scarab Genomics technologies in the Japanese market. Through this collaboration, researchers and biomanufacturing organizations in Japan gain expanded access to the Clean Genome E. coli platform supported by regional expertise and local engagement. World Fusion brings deep experience supporting life science organizations in Japan with technical requirements alignment.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-05-06
Description

Joint webinar collaboration for Scale Smarter event demonstrating plasmid DNA production optimization using Clean Genome strains, smart bioprocessing tools, and engineered E. coli strains. Scarab participated alongside Bionova Scientific, INFORS HT, and Thomson Instrument Company.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Supplies engineered E. coli strains and cloning tools for protein and nucleic acid production, including CloneDirect and overexpression hosts. Directly comparable as a specialty E. coli host platform serving the same molecular biology and bioproduction customers.

TypeDirect peer
Description

Major supplier of E. coli competent cells (NEB 5-alpha, BL21 derivatives) and protein expression reagents. Overlaps with Scarab's Clean Genome® strain catalog in serving academic and industrial protein expression researchers.

TypeDirect peer
Description

Provides molecular biology tools including competent cells, plasmid purification, and nucleic acid processing kits. Comparable as a tools-focused private company serving similar biotech research and bioproduction workflows.

TypeDirect peer
Description

Specializes in CRM197 carrier protein production and conjugation technologies for conjugate vaccines. Directly competes with Scarab's CRM197 protein offering in the vaccine carrier protein market.

TypeBroad incumbent
Description

CDMO specializing in mRNA synthesis, plasmid DNA production, and nucleic acid manufacturing. Comparable as a larger incumbent in the pDNA/mRNA manufacturing value chain that Bionova (Scarab's licensee) serves.

TypeBroad incumbent
Description

Leading CDMO for plasmid DNA, mRNA, and protein biologics, now part of Danaher. Represents a much larger incumbent in the same pDNA/mRNA manufacturing value chain targeted by Clean Genome® applications.

TypeBroad incumbent
Description

Supplies BL21(DE3) and other E. coli expression strains through its Life Sciences portfolio, alongside broader protein and bioprocessing offerings. The dominant incumbent whose standard platforms Clean Genome® must displace or complement.

TypeBroad incumbent
Description

Major bioprocessing equipment and consumables supplier, including continuous fermentation platforms. Relevant incumbent whose continuous-manufacturing infrastructure could compete with or complement C-Flow technology.

TypeEmerging player
Description

Specialty manufacturer of plasmid DNA and viral vectors for research, gene therapy, and cell therapy applications. Comparable emerging specialist in the pDNA value chain that Clean Genome® enables.

TypeEmerging player
Description

Supplies nucleic acid synthesis, oligos, and custom molecular biology tools including E. coli-based reagents. Comparable emerging tools provider in synthetic biology and nucleic acid production markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Scarab Genomics LLC.

Bioprocessing and Synthetic Biology Reagentsscarabgenomics.com

Scarab Genomics LLC develops and commercializes engineered reduced-genome Clean Genome® E. coli strains, vaccine carrier proteins, and C-Flow™ continuous fermentation technology for biopharmaceutical manufacturers, CDMOs, vaccine developers, and academic researchers producing recombinant proteins and nucleic acids.

What Scarab Genomics LLC. does

Scarab Genomics LLC, founded in 2002 in Madison, Wisconsin by Professor Frederick Blattner, commercializes engineered reduced-genome E. coli host strains under the Clean Genome® brand, derived from the MDS42 strain published in Science 312:1044-6. Its core platform removes approximately 20% of the E. coli genome, including all mobile genetic elements, insertion sequences, bacteriophages, and nonessential genes, delivering enhanced genetic stability and enabling long continuous fermentation runs. The C-Flow™ continuous fermentation system (US Patent 10,604,736) allows kilogram-scale biopharmaceutical production in 10-liter fermenters, and complementary IP (US Patent 11,174,284) covers improved CRM197 purification for conjugate vaccine manufacturing.

The company sells a catalog of Clean Genome® variants (base, ΔrecA, LowMut, LowMut ΔrecA Blue, LowMut T7, plus specialty strains for dsRNA, low endotoxin, methylation-deficient, protease-deleted, and toxin-antitoxin-deleted applications), vaccine carrier proteins (CRM197 and Protein D), the pSX2 expression vector, and an Insertion Sequence Detection Kit. Pricing on the self-serve e-commerce store ranges from $225 to $3,350 per unit. Scarab serves academic researchers under a limited license, biopharmaceutical manufacturers and CDMOs under negotiated commercial licenses, and has granted Bionova Scientific an exclusive license for plasmid DNA production (February 2026), with World Fusion distributing in Japan from December 2025. Revenue is generated through product sales, academic and commercial licensing royalties, and exclusive technology licensing arrangements.

Scarab Genomics LLC. firmographics

Firmographics
Name
Scarab Genomics LLC.
Legal name
Scarab Genomics LLC
Website
https://scarabgenomics.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
Scarab Genomics LLC develops and commercializes engineered reduced-genome Clean Genome® E. coli strains, vaccine carrier proteins, and C-Flow™ continuous fermentation technology for biopharmaceutical manufacturers, CDMOs, vaccine developers, and academic researchers producing recombinant proteins and nucleic acids.
Ownership category
akta.pro rank

Scarab Genomics LLC. industry classification

Industry
Product category
Bioprocessing and Synthetic Biology Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGAGAC
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAAAKAE
Plasmid DNA & mRNA Manufacturing Services
SECONDARYHLAAAEAD
Vaccine Technology Platforms (mRNA, viral vector, protein subunit, inactivated/live-attenuated, VLP, DNA)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAAAAAB
Recombinant Protein Therapeutics (enzymes, hormones, growth factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAACAN
Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)

Keywords

  • Engineered E. coli strains
  • Vaccine carrier proteins
  • Continuous fermentation
  • Recombinant protein expression
  • Plasmid DNA production

Where Scarab Genomics LLC. is headquartered

Location

Headquarters

HQ city
Madison
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Scarab Genomics LLC. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Product Sales: Direct sales of Clean Genome E. coli competent cells, vaccine carrier proteins (CRM197, Protein D), expression vectors, and detection kits through e-commerce platform. Products available in various sizes with pricing from $225 to $3,350.
  2. Academic Licensing: Limited Use License Agreement for academic research use of Clean Genome strains; requires signed agreement prior to shipping.
  3. Commercial Licensing: Commercial licenses negotiated for production use of Clean Genome E. coli and C-Flow fermentation technology; includes access to technical experts for strain and expression optimization.
  4. Exclusive Technology Licensing: Partnership with Bionova Scientific granting exclusive rights for Clean Genome strains in specific applications (plasmid DNA production), with licensing fees and potential milestone payments.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goClean Genome E. coli competent cells
Unit PricingPay-as-you-goCRM197 protein vaccine carrier
Unit PricingPay-as-you-goProtein D vaccine carrier
Unit PricingPay-as-you-gopSX2 Expression Vector
Unit PricingPay-as-you-goInsertion Sequence Detection Kit
OtherPay-as-you-goShipping and Handling
SubscriptionAnnualAcademic Research License
Licensing/ royaltiesMulti-year contractCommercial Production License

Go-to-market motion4 records

Distribution channels4 records

Marketing channels8 records

Scarab Genomics LLC. product offering

Product offering

Core offering

Scarab Genomics LLC develops and commercializes Clean Genome® engineered reduced-genome E. coli strains for high-efficiency production of recombinant proteins and nucleic acids, including biopharmaceutical manufacturing. The company also sells vaccine carrier proteins (CRM197 and Protein D), the pSX2 expression vector, an Insertion Sequence Detection Kit, and licenses its C-Flow™ continuous fermentation technology for commercial-scale biopharmaceutical production.

Product overview

Scarab Genomics LLC offers a platform of Clean Genome® engineered E. coli strains for high-efficiency production of recombinant proteins and nucleic acids. The core product line includes Clean Genome® base strain and specialized variants (ΔrecA, LowMut, LowMut ΔrecA, LowMut ΔrecA Blue, LowMut T7), all derived from the MDS42 reduced-genome strain. Supporting products include vaccine carrier proteins CRM197 and Protein D for conjugate vaccine research, the pSX2 expression vector, and the Insertion Sequence Detection Kit for quality control. The C-Flow™ continuous fermentation system enables scalable biopharmaceutical production with small-footprint equipment. Products are available for research use via limited license and for commercial use through licensing agreements.

Differentiator

Problem solved

Functional benefit

Brands

  • Clean Genome: Engineered E. coli strains with reduced genomes for enhanced genetic stability and improved metabolic efficiency in protein and nucleic acid production.
  • C-Flow
  • ScarabXpress

Quantifiable outcome

  • Continuous fermentation runs up to 65 days with consistent production levels
  • +5 more outcomes

Companies that use Scarab Genomics LLC.

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles1 record

Scarab Genomics LLC. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature12 records

Scarab Genomics LLC. partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Bionova ScientificcoreStrategic or Co-development Partner · 5 February 2026Partnership enables Bionova to leverage Clean Genome platform eliminating mobile genetic elements and minimizing genomic instability to achieve higher plasmid yields and improved lot-to-lot consistency for advanced biologics manufacturing.
  • Bionova ScientificcoreOEM/ Whitelabel/ Licensing Partner · 3 February 2026Exclusive licensing partnership granting Bionova Scientific rights to use Scarab's proprietary Clean Genome engineered E. coli strains for plasmid DNA production. The partnership enables Bionova to support client programs across mRNA, viral vectors, and emerging genetic medicine platforms with scalable, regulatory-aligned manufacturing solutions. Bionova operates protein operations in Fremont, California and plasmid DNA facility in Houston, Texas.
  • World FusioncoreChannel Partner/ Reseller/ Distributor · 22 December 2025World Fusion serves as the authorized distributor of Scarab Genomics technologies in the Japanese market. Through this collaboration, researchers and biomanufacturing organizations in Japan gain expanded access to the Clean Genome E. coli platform supported by regional expertise and local engagement. World Fusion brings deep experience supporting life science organizations in Japan with technical requirements alignment.
  • Thomson Instrument Company, INFORS HT, Bionova ScientificminorGTM or Marketing Partner · 6 May 2025Joint webinar collaboration for Scale Smarter event demonstrating plasmid DNA production optimization using Clean Genome strains, smart bioprocessing tools, and engineered E. coli strains. Scarab participated alongside Bionova Scientific, INFORS HT, and Thomson Instrument Company.

Scale indicators9 records

Recent moves5 records

Expansion highlights5 records

Scarab Genomics LLC. competitors and assessment

Company assessment

Direct peers

  • Lucigen (Biosearch Technologies): Supplies engineered E. coli strains and cloning tools for protein and nucleic acid production, including CloneDirect and overexpression hosts. Directly comparable as a specialty E. coli host platform serving the same molecular biology and bioproduction customers.
  • New England Biolabs: Major supplier of E. coli competent cells (NEB 5-alpha, BL21 derivatives) and protein expression reagents. Overlaps with Scarab's Clean Genome® strain catalog in serving academic and industrial protein expression researchers.
  • Zymo Research: Provides molecular biology tools including competent cells, plasmid purification, and nucleic acid processing kits. Comparable as a tools-focused private company serving similar biotech research and bioproduction workflows.
  • Fina Biosolutions: Specializes in CRM197 carrier protein production and conjugation technologies for conjugate vaccines. Directly competes with Scarab's CRM197 protein offering in the vaccine carrier protein market.

Broad incumbents

  • TriLink BioTechnologies: CDMO specializing in mRNA synthesis, plasmid DNA production, and nucleic acid manufacturing. Comparable as a larger incumbent in the pDNA/mRNA manufacturing value chain that Bionova (Scarab's licensee) serves.
  • Aldevron (Danaher): Leading CDMO for plasmid DNA, mRNA, and protein biologics, now part of Danaher. Represents a much larger incumbent in the same pDNA/mRNA manufacturing value chain targeted by Clean Genome® applications.
  • Thermo Fisher Scientific: Supplies BL21(DE3) and other E. coli expression strains through its Life Sciences portfolio, alongside broader protein and bioprocessing offerings. The dominant incumbent whose standard platforms Clean Genome® must displace or complement.
  • Sartorius: Major bioprocessing equipment and consumables supplier, including continuous fermentation platforms. Relevant incumbent whose continuous-manufacturing infrastructure could compete with or complement C-Flow technology.

Emerging players

  • PlasmidFactory: Specialty manufacturer of plasmid DNA and viral vectors for research, gene therapy, and cell therapy applications. Comparable emerging specialist in the pDNA value chain that Clean Genome® enables.
  • Biosearch Technologies (LGC Group): Supplies nucleic acid synthesis, oligos, and custom molecular biology tools including E. coli-based reagents. Comparable emerging tools provider in synthetic biology and nucleic acid production markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Scarab Genomics LLC. social profiles

Digital presence

Scarab Genomics LLC. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Scarab Genomics LLC. leadership team

Management profile

Number of profiles

Profiles10 records

Scarab Genomics LLC. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Scarab Genomics LLC. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scarab Genomics LLC.

What does Scarab Genomics LLC. do?

Scarab Genomics LLC develops and commercializes Clean Genome® engineered reduced-genome E. coli strains for high-efficiency production of recombinant proteins and nucleic acids, including biopharmaceutical manufacturing. The company also sells vaccine carrier proteins (CRM197 and Protein D), the pSX2 expression vector, an Insertion Sequence Detection Kit, and licenses its C-Flow™ continuous fermentation technology for commercial-scale biopharmaceutical production.

Is Scarab Genomics LLC. a public or private company?

Scarab Genomics LLC. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Scarab Genomics LLC. founded?

Scarab Genomics LLC. was founded in 2002. It employs 11 to 50 people.

Where is Scarab Genomics LLC. based?

Scarab Genomics LLC. is headquartered in Madison, United States, in the North America region.

How does Scarab Genomics LLC. make money?

Four revenue lines are on record. Product Sales are the primary driver. The others are academic Licensing, commercial Licensing and exclusive Technology Licensing.

Who are Scarab Genomics LLC.'s main competitors?

Direct peers on record are Lucigen (Biosearch Technologies), New England Biolabs, Zymo Research and Fina Biosolutions. Broad incumbents are TriLink BioTechnologies, Aldevron (Danaher), Thermo Fisher Scientific and Sartorius. Emerging players are PlasmidFactory and Biosearch Technologies (LGC Group).

Does Scarab Genomics LLC. have an API?

No public API is recorded for Scarab Genomics LLC..

What industry is Scarab Genomics LLC. in?

Scarab Genomics LLC.'s product category is Bioprocessing and Synthetic Biology Reagents. Its primary akta.pro industry code is HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA), with a secondary code of HLAAAKAE, Plasmid DNA & mRNA Manufacturing Services. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales